Serum metabolic biomarkers discovery study of esophageal squamous cell carcinoma in china
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700697P
- Awardee
-
Cancer Hospital, Chinese Academy Of Medical Sciences UEI XLTPGYWWMUP3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,000
Award facts
- Opportunity
-
- NO2CP7266736A Solicitation number
- Contract value 100% obligated
- $20,000.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- China
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$28,860 | |
| Original award | $48,860 |
Quick answers
Who was awarded contract HHSN261201700697P?
HHSN261201700697P was awarded to Cancer Hospital, Chinese Academy Of Medical Sciences by National Cancer Institute (National Institutes of Health) on September 18, 2017.
How much is contract HHSN261201700697P worth?
The government has obligated $20,000 on HHSN261201700697P.
Was contract HHSN261201700697P competed?
The extent of competition for HHSN261201700697P was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award